We need a proper roadmap for building the 5G ecosystem
24 Oct 2018 – 10:00 | No Comment

Developing and accelerating 5G infrastructure is a key enabler for the Digital Single Market. The deployment and utilisation of 5G wireless systems is essential for the EU to remain at the forefront of global digital …

Read the full story »
Health

Energy & Environment

Circular Economy

Climate Change

Security

Active surveillance – a great alternative to curative therapies
30 Mar 2016 – 17:29
Active surveillance – a great alternative to curative therapies

The ‘active surveillance’ protocol has become an alternative to curative therapy for prostate cancer that is unlikely to be biologically or clinically significant. However, Dr Riccardo Valdagni, Director, Radiation Oncology, European School of Oncology says …

Innovative therapies must be made accessible to all
30 Mar 2016 – 17:27
Innovative therapies must be made accessible to all

Access pathways must foster innovation to address unmet needs, align evidence requirements as treatment options move earlier in the disease course, and remove barriers to access for patients. Jane Griffiths, Group Chairman, Janssen Europe, Middle …

Symptoms, treatment, follow-up & everything about PCa
30 Mar 2016 – 17:16
Symptoms, treatment, follow-up & everything about PCa

Dr. Laurent Fossion, M.D., Urologist, FeBU, gives the whole picture on care, prevention and treatment of prostate cancer in Europe
Exact causes for prostate cancer are still unknown, but dietary habits (Western feeding pattern) and genetic …

From therapeutic nihilism to diversity in treatment options – what can be added?
30 Mar 2016 – 17:11
From therapeutic nihilism to diversity in treatment options – what can be added?

Despite extensive use of radical treatments, such as surgery and radiotherapy, and constant technical innovations, mortality rates remain high. Prof Bertand Tombal, Consultant Urologist, Brussels Saint-Luc University Hospital lists out whats missing in the battle …

Calling for a compulsory screening mechanism in UK
30 Mar 2016 – 17:06
Calling for a compulsory screening mechanism in UK

All cancers are required to be diagnosed sufficiently early if treatment should to be successful and prostate cancer appears to be the most difficult as patients often show no early symptoms. Gary Steele, M.B.E, Chairman, …

Improving European healthcare with evidence-based information
30 Mar 2016 – 16:59
Improving European healthcare with evidence-based information

For almost 40 years, the European Association of Urology has addressed the most pressing concerns of urological diseases. Prof. Dr. Nicolas Mottet and Prof. Dr. Hein Van Poppel — on behalf of the EAU — …

Rethinking doctor-patient relationships in a digital era
30 Mar 2016 – 16:38
Rethinking doctor-patient relationships in a digital era

Though we live in a digital era, most patients reportedly leave their oncologists’ clinics with several questions unanswered. Prof. Louis Denis, M.D. FACS gives a re-think about the relationships
A great deal of patient dissatisfaction and several …

The role of MRI in prostate cancer expands
30 Mar 2016 – 15:25
The role of MRI in prostate cancer expands

The role of imaging techniques such as multiparametric MRI (mpMRI) in prostate cancer is set to expand in the coming years, particularly in cases where technology is more integrated with treatment. Prof Jelle Barentsz, Professor …

Integrated services: (how) does it work?
30 Mar 2016 – 15:15
Integrated services: (how) does it work?

Local public social services rise to the integration challenge.  John Halloran, CEO and Alfonso Lara Montero, Policy Director, The European Social Network share their experiences from a recent seminar on integrated services

On 5-6 November, more …

Targeted prostate biopsy gets cost-effective
30 Mar 2016 – 14:58
Targeted prostate biopsy gets cost-effective

Exact Imaging’s breakthrough ExactVu™ micro-ultrasound system enables a 300% improvement in resolution over the current ultrasound systems. Urologists can now accurately visualise suspicious regions in the prostate and better target biopsies for better and more …